This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Sumitomo Pharma Co., Ltd., Sumitomo Pharma Co., Ltd.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Hirotaka Miyachi: Innovator in Medicinal Chemistry
Introduction
Hirotaka Miyachi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating neurological disorders.
Latest Patents
Miyachi holds a patent for an oxadiazole derivative, which is a compound designed to treat and prevent diseases such as epilepsy. The patent describes a compound of formula (1), where Q can be a halogen atom or a hydrogen atom, and X, Y, and Z can be nitrogen or oxygen atoms. The compound also includes a specific structure for R or a pharmaceutically acceptable salt thereof.
Career Highlights
Hirotaka Miyachi is associated with Sumitomo Pharma Co., Ltd., where he has been instrumental in advancing research in pharmaceutical development. His work has led to innovative solutions in the treatment of various medical conditions.
Collaborations
Miyachi has collaborated with notable colleagues, including Yoshiaki Isobe and Tomoyuki Tanaka, to further enhance the research and development of medicinal compounds.
Conclusion
Hirotaka Miyachi's contributions to medicinal chemistry and his innovative patent for an oxadiazole derivative highlight his role as a key figure in the pharmaceutical industry. His work continues to impact the treatment of neurological diseases, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile